Podcasts

Episode 94: Understanding Neurogenic Orthostatic Hypotension

Among the many non-motor symptoms of Parkinson’s disease (PD) are blood pressure changes. One manifestation is neurogenic orthostatic hypotension, a condition in which blood pressure drops sharply when one moves from a reclining to a more upright position, such as standing up when getting out of bed or rising from a chair. The person may feel lightheaded, dizzy, lose balance, or, rarely, even lose consciousness. Besides being uncomfortable, the condition can be dangerous if it leads to a fall and subsequent injury. Orthostatic hypotension is common in mid- and late-stage PD, but it may also be an early sign of the disease.

Fortunately, there are strategies and other measures people can do for themselves to lessen the problem, and a variety of medications may help. Other conditions and medications can also lead to the condition, and they should be investigated in addition to a connection with PD. In this podcast, neurologist Dr. Katie Longardner of the University of California San Diego discusses the problem, how it is diagnosed, what people can do to alleviate it, and some of the research she and others are conducting.

Released: December 1, 2020

Read the Transcript

Podcasts

Episodio 22: Cambios cognitivos

Cuando uno piensa en la enfermedad de Parkinson (EP), es fácil asociarla más con los síntomas motores, como la rigidez o el temblor; pero también existen síntomas no motores, como los cambios de estado de ánimo, la ansiedad o la depresión.

En este episodio, hablamos con la doctora Elsa Baena, neuropsicóloga clínica en el Barrow Neurological Institute, Centro de Excelencia de la Parkinson’s Foundation, acerca de estos cambios cognitivos asociados con el Parkinson.

La doctora Baena explica la conexión entre el Parkinson y la cognición y cómo pueden prepararse las personas con Parkinson para estos cambios (no sólo las maneras farmacológicas, sino también las terapéuticas).

Asimismo aprenderemos acerca de los miembros del equipo de atención médica que pueden apoyar a una persona con Parkinson y a sus familiares con estos cambios cognitivos.

Lanzado: 18 de octubre de 2022

Podcasts

Episode 191: Speaking with Intention

Changes in speech and swallowing are common in Parkinson’s disease (PD), but they can be difficult to recognize without understanding how they may present. These changes often happen because of lower dopamine levels in people with PD, which can make automatic actions- like speaking loud, clear sentences without requiring much thought- more difficult.  

The Parkinson Voice Project developed the SPEAK OUT! Therapy Program to help people with PD speak and swallow with intention, addressing these challenges. 

In the episode, we speak with Samantha Elandary, MA, CCC-SLP, President and Chief Executive Officer of the Parkinson Voice Project. She discusses the benefits of working with a Certified SPEAK OUT! Provider, how to identify signs of speech and swallowing difficulties, and offers tips for incorporating these techniques into daily life. Toward the end of the episode, Samantha demonstrates a brief speech exercise that takes just a few minutes but can provide meaningful benefits when practiced consistently and intentionally. 

Released: May 12, 2026

Fact Sheets

Therapies to Help You Live Better with Parkinson's

Physical, occupational and speech therapy can help manage symptoms and support daily life with Parkinson’s disease (PD). These therapies are a key part of PD care.

When should therapy start?

People often begin therapy when symptoms become more noticeable, but it can help at any stage of Parkinson’s. Starting therapy early and continuing over time is especially helpful.

Think of it like going to the dentist for checkups — regular visits help prevent problems, not just treat them.

How does therapy help?

Physical, occupational and speech therapists focus on different parts of daily life.

Physical therapy helps with:

  • Walking and overall movement

  • Balance and fall prevention

  • Strength and flexibility

  • Exercise and staying active

Occupational therapy helps with:

  • Daily tasks like dressing, cooking, driving and using technology

  • Home setup for safety and comfort

  • Staying involved in work, hobbies and daily routines

Speech therapy helps with:

  • Speech and voice

  • Thinking and communication skills

  • Everyday conversations

  • Swallowing (food, drinks and pills)

Do I need all three types of therapy?

A visit with each can help you establish a baseline (a clear picture of your current abilities), connect with a therapist you can work with over time and decide where to start.

How does therapy work?

Therapy is based on your needs and goals. It often focuses on small changes to help keep movement, daily tasks and communication as smooth as possible. It can also address specific Parkinson’s challenges. Here’s what to expect:

Step 1: Talk with your care team

Tell your care team you are interested in physical, occupational or speech therapy. A referral is often needed. Your care team may be able to suggest therapists trained in Parkinson’s care.

Step 2: Meet with your therapist and set goals

At your first appointment, your therapist will look at your abilities and needs. Together, you will set realistic goals based on what matters most to you right now. These might include building strength, walking more steadily, managing daily tasks like dressing or eating or speaking louder.

Step 3: Continue therapy and practice at home

Therapy may be a few sessions or continue over several weeks or longer, depending on your needs and goals. You will likely have exercises to do at home. Let your therapist know what is working and what is not so your program can be adjusted as needed.

Step 4: Schedule follow-up visits

Follow-up visits help track your abilities, review goals and adjust strategies and exercises as needed. Many people check in with a therapist about once a year, or more as needed. These visits help you notice new challenges and address them early.

Videos & Webinars

Understanding Cognition & Thinking Changes in Parkinson’s

March 19, 2026

Changes in memory, attention, and problem-solving are common non-motor symptoms of Parkinson’s that can affect daily life, relationships, and independence. In this webinar, we’ll explore how Parkinson’s impacts cognitive function and what veterans and care partners can do to recognize, manage, and adapt to these changes. We'll also discuss when to seek additional support, how the VA addresses cognitive health, and which tools and therapies may help maintain brain function and quality of life. 

Download Slides

Additional Resources

Presenters

Anita Sim, PhD 
Neuropsychologist, Minneapolis VA Health Care System  

Christy Becker, MA, CCC-SLP 
Speech-Language Pathologist, Minneapolis VA Health Care System

Konner Kielman, OTD, OTR/L, LSVT BIG Certified 
PD/MD Staff Occupational Therapist, Minneapolis VA Health Care System

My PD Story

Nancy and her husband outside
Care Partners

Nancy Carstens

My husband spent his career building commercial and industrial projects around the country. Many years ago, he lost his sense of smell, which he attributed to being around chemicals on project sites. He also developed chronic constipation, which we thought was related to traveling and not maintaining a proper diet.

In 2018, while living in Atlanta, GA, for a project, he lost 20 pounds. We thought it was because he was cooking for himself and not eating second helpings. In 2019, we were in London, where you do a lot of walking. I noticed that he was shuffling his feet, but he said it was his shoes or the flooring. This continued when we returned home.

One day I noticed a slight tremor, but he said it was just the way he was reaching for something. He didn’t take my concerns seriously until 2020, when he was at work and was too stiff to put on his jacket and had to ask for help.

We saw a neurologist early in 2021, who referred us to a Movement Disorders Specialist. That specialist made the diagnosis of Parkinson’s disease, saying that he had probably had it for 10 years.

My husband’s movement symptoms have responded well to medication. However, he quickly began to exhibit non-movement symptoms ranging from anxiety and language issues to now symptoms of dementia.

As for myself, along with being his care partner — and more recently, his caregiver — I try to turn our mess into our message by serving as an Ambassador for the Parkinson’s Foundation, an Executive Board Member for our local chapter and a Research Advocate.

My husband’s father also had Parkinson’s disease, and we have two daughters, so we were interested in learning whether there might be a genetic factor involved. We enrolled him in PD GENEration, the Parkinson’s Foundation genetic study. The process was incredibly easy, and his results did not show a genetic link.

It felt great to participate, both for us and to help advance research. It was also meaningful to be able to tell our daughters that no genetic link was determined.

Explore ways to volunteer with the Parkinson’s Foundation and become a Parkinson’s Foundation AmbassadorSign up now.

My PD Story

Donna Parkhurst headshot
People with PD

Donna Parkhurst

Parkinson’s disease (PD) entered my life long before my own diagnosis. Not too many years ago, I walked the caregiving journey alongside my mother as she lived with Parkinson’s and eventually passed away from its complications. Watching someone you love face the progression of this disease is heartbreaking, and it gave me a deep respect for both the strength of people living with Parkinson’s and the quiet resilience of caregivers.

Because of that experience, when I was diagnosed with Parkinson’s myself, it felt surreal. Suddenly I was no longer just the caregiver. I was the patient.

Like many people newly diagnosed, I had to face the uncertainty that comes with Parkinson’s. Some days I function very well, but there is always the question in the background: what will the future look like? Learning to live with that uncertainty has been one of the biggest challenges.

Another realization was that Parkinson’s is about far more than tremors or movement. Many symptoms are invisible — fatigue, anxiety, brain fog, sleep disruption, constipation and stress sensitivity. These symptoms can affect daily life in ways that others may not see or fully understand.

What has helped me most is focusing on the things I can control. Staying active, managing stress, prioritizing healthy habits, and leaning on supportive relationships have all played an important role in how I live with Parkinson’s today.

I’m incredibly grateful for a loving and supportive husband and family who walk alongside me on this journey.

One unexpected gift of this diagnosis has been the opportunity to connect with others in the Parkinson’s community. I began sharing my experiences online to bring awareness to both the visible and invisible aspects of Parkinson’s. What I discovered is that many people living with Parkinson’s — and their caregivers — simply want to feel seen, heard and understood.

Those conversations have become deeply meaningful to me. If sharing my story helps even one person feel less alone, better informed, or more hopeful, then something good is coming from this difficult diagnosis.

Participating in research has also become important to me. I enrolled in PD GENEration, the Parkinson’s Foundation genetic study. The process was extremely straightforward — easy, painless and honestly very impressive in how they carried out the entire experience.

Participating made me feel seen and valued, and I felt honored to contribute to research that may help others in the future. I was also relieved to learn that I do not carry a known genetic component to pass on to my children.

This was my first time participating in a Parkinson’s research study, but it won’t be my last. I’m very open to participating in future studies whenever possible. I also shared my genetic results with my family.

What keeps me hopeful is the resilience of the Parkinson’s community and the progress being made in research and treatment. Organizations like the Parkinson’s Foundation play an essential role by providing trusted education, resources, and advocacy that empower people living with Parkinson’s and their families.

If I could give advice to someone newly diagnosed, it would be this: take a deep breath. Parkinson’s looks different for everyone, and many people live well for decades. Stay active, build a strong care team, and stay connected to others who understand the journey.

Parkinson’s has changed parts of my life, but it has also deepened my sense of purpose. Today, I try to use my voice to raise awareness, encourage others living with Parkinson’s, and remind people that even in the face of uncertainty, there is still life to be lived, community to be found, and hope to hold onto.

Explore ways to get involved with Parkinson’s research today. Visit our Join A Study page and learn more about PD GENEration, the Parkinson’s Foundation genetics study that offers genetic testing and counseling at no cost to participants.

Science News

Orthostatic Hypotension in Parkinson’s Raises Long-Term Fall Risk

Parkinson's Foundation Science News blogs

Orthostatic hypotension (OH) — a significant drop in blood pressure that occurs when you stand up — is one of the most common non-movement symptoms of Parkinson’s disease (PD). It can cause dizziness, blurred vision, fatigue, and difficulty thinking, which can lead to falls. Generally, OH is also associated with cardiovascular problems (issues with the heart). Together, these risks highlight the importance of understanding how OH impacts health outcomes, especially in people with Parkinson’s.

A new nationwide study, published in Parkinsonism & Related Disorders, explores the longer-term consequences for people with Parkinson’s who experience OH. The study was led by Hikaru Kamo, MD, PhD, a 2025 Melvin Yahr Parkinson’s Disease Clinical Research Award recipient. Dr. Kamo and his research team, based at the University of Florida’s Norman Fixel Institute for Neurological Diseases, also included collaborators from the Parkinson’s Foundation.

Study Results

Using a nationwide insurance claims database, the research team analyzed records from 111,368 adults with Parkinson's disease, of whom 2,598 had a documented diagnosis of OH. After using statistical methods to account for differences between the two groups — such as age, other medical conditions and medications — the team found that people with Parkinson's and OH had a 35% higher chance of experiencing a fall over five years compared to those with Parkinson's alone. They also accumulated more total falls over time.

However, despite long-standing concerns that OH might put extra strain on the heart and blood vessels, the study found no significant link between OH and major cardiovascular events such as heart attack or stroke.

Among those with OH who were taking commonly prescribed medications for the condition, such as midodrine or fludrocortisone, fall risk was 34% higher compared to those not on these drugs, with no added cardiovascular benefit.

However, the study authors suggest that the most likely explanation is that people with more severe OH symptoms are more likely to be prescribed medication for the condition, and as a result are more likely to experience falls regardless of medication use. At this point, it should not be considered a cause-and-effect relationship until additional studies investigate further.

Overall, these findings were consistent across analyses, suggesting that OH in Parkinson's is more likely to lead to problems with falls compared to cardiovascular issues. Therefore, treatment for OH in Parkinson’s should place a strong emphasis on fall prevention.

Highlights

  • People with Parkinson's and OH had a 35% higher chance of experiencing a fall over five years compared to those with Parkinson's alone. They also accumulated more total falls over time.
  • Despite concerns that OH might strain the heart and blood vessels, the study found no significant link between OH and major cardiovascular events such as heart attack and stroke.
  • Among those with OH, people taking common OH medications (such as midodrine or fludrocortisone) had a 34% higher fall risk compared to those not on these drugs, without any added cardiovascular benefit.
  • In people with Parkinson’s and OH, fall risk is the main safety concern compared to cardiovascular events.

What does this mean?

This study supports that orthostatic hypotension in Parkinson’s is more of a fall-risk issue instead of a cardiovascular one. While that is reassuring news on the heart-health side, it underscores the importance of addressing fall prevention as a top priority for people living with Parkinson's and OH.

This research also indicates that more studies are needed on the impact of OH medications. Current research suggests that OH medications primarily treat the symptoms of OH, rather than treating the underlying cause of the condition. While these results of this study show that fall risk is higher in people with Parkinson’s taking OH medication compared to those without medication, the authors suggest that this may be a misleading association. To determine a cause-and-effect relationship, further studies on this topic are needed.

How do these findings impact people with Parkinson’s right now?

Overall, the message to the Parkinson’s community is that OH should be viewed primarily as a mobility and safety issue rather than a heart problem. This study adds important evidence about the real-world impact of OH in Parkinson’s and points to the need for better fall-prevention strategies and further study of treatment approaches.

PD care should prioritize fall prevention strategies, regardless of OH status. For people with PD and care partners, this means greater emphasis on lifestyle approaches such as fall-prevention programs, physical therapy, balance training, home safety modifications and knowing if medications can increase fall risk.

If you experience OH symptoms — such as weakness, difficulty thinking, headaches and blurred or dimmed vision — discuss them with your doctor.

Learn More

The Parkinson’s Foundation believes in empowering the Parkinson’s community through education. Learn more about PD and orthostatic hypotension through our resources below, or by calling our free Helpline at 1-800-4PD-INFO (1-800-473-4636) for answers to your Parkinson’s questions.

Advancing Research

Meet the Researcher Working to Restore Sleep in Parkinson’s

🧠 What will you learn in this article?

This article highlights a researcher working to understand how Parkinson’s disease (PD) impacts sleep. It discusses: 

  • How PD changes neuron behavior in a specific sleep-regulating region.
  • How results of this study can inform future treatments for sleep issues in people with PD.
  • How support from the Parkinson’s Foundation makes research like this possible.
Pamela Marcott headshot

Beyond the most visible movement-related symptoms, people with Parkinson’s disease (PD) also experience non-movement symptoms. These symptoms can be debilitating and are sometimes more difficult for care partners to recognize.

One common non-movement PD symptom is difficulty sleeping, often in the form of waking up frequently throughout the night. Pamela Marcott, MD, PhD, a recipient of a Parkinson’s Foundation Postdoctoral Fellowship, is casting a spotlight on the sleep-associated circuits of the brain to understand how exactly PD impacts sleep patterns. By uncovering the mechanisms behind PD-related sleep problems, she hopes to help advance new therapies for such disturbances.

While much of the neuroscience of sleep is still a mystery, researchers do know that staying asleep through the night requires a highly calibrated balance of different signals in the brain. These sleep signals are relayed through brain cells called neurons and can vary in frequency and intensity, depending on their purpose. If these signals become altered and imbalanced, sleep fragmentation occurs with "frequent changes between different sleep and wake states, leading to less consolidated and restful sleep,” said Dr. Marcott.

Under the mentorship of Alexandra Nelson, MD, PhD, and Ying-Hui Fu, PhD, at the University of California, San Francisco, a Parkinson’s Foundation Center of Excellence, Dr. Marcott is investigating how PD changes the behavior of neurons in a specific sleep-regulating region of the brain called the pedunculopontine nucleus (PPN). PPN neurons act like telephone operators, relaying important signals across the brain. Using mice with and without PD-like symptoms, she will measure how the disease affects the ability of PPN neurons to transmit their important sleep signals.

 “Results of this study will improve our understanding of the circuit mechanisms that regulate sleep disturbances in PD, which will inform future therapeutic treatments,” said Dr. Marcott.

After learning more about how PD changes the sleep-related neurons’ signaling ability, Dr. Marcott will then monitor the brains of the mice as they sleep. She will keep a close eye on how the PPN neurons activate during sleep phase transitions, as she believes PD causes these neurons to be overactive and lead to fragmented sleep.

Observing in real time how PD alters sleep regulation in the brain will provide a strong foundation for understanding how to treat this symptom and give restful nights back to people with PD.

“I have been both personally and professionally affected by Parkinson's disease and have dedicated my career to improving the lives of patients living with Parkinson's and their families.” - Dr. Marcott

“This award is a powerful acknowledgment not just of the work I've done, but also of the work I hope to do in the future to improve care for patients with Parkinson's disease,” said Dr. Marcott. “As a physician scientist in this space, I am committed to making meaningful discoveries in the laboratory that will benefit my patients, and I am excited to have the opportunity to start this phase of my career with the support of the Parkinson's Foundation.”

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers.

Science News

Treating Sleep Apnea May Lower Parkinson’s Risk

🧠 What will you learn in this article?

This article highlights a new study that found that untreated obstructive sleep apnea (OSA) may increase the risk of developing Parkinson’s disease. It discusses:

  • How up to 40% of people with Parkinson’s experience sleep apnea.
  • People with untreated obstructed sleep apnea had nearly twice the risk of developing Parkinson's disease compared to those without OSA.
  • Early continuous positive airway pressure (CPAP) treatment in those with OSA significantly reduced the number of Parkinson's cases.
  • Benefits of early CPAP use for people with Parkinson’s.
Parkinson's Foundation Science News blogs

Sleep problems are a common non-movement symptom for people who live with Parkinson’s disease (PD). However, a new large-scale study reveals that untreated obstructive sleep apnea (OSA) may actually increase the risk of developing Parkinson’s disease in the first place, but treating it with continuous positive airway pressure (CPAP) may help reduce that risk.

Obstructive sleep apnea is a condition where breathing repeatedly stops and starts during sleep due to a blocked or narrowed airway. This prevents the body from getting enough oxygen, disrupting sleep quality and putting stress on various organs, including the brain. An estimated 30 million Americans have OSA, though many remain undiagnosed.

Study Results

The study, published in JAMA Neurology, and led by researchers at Oregon Health & Science University and the Portland VA Health Care System analyzed electronic health records from veterans who received care through the Department of Veterans Affairs between 1999 and 2022.

Of the more than 11 million veterans included in the analysis, about 1.5 million (13.7%) had OSA. After adjusting for factors like age, obesity and cardiovascular conditions, the researchers found a strong link between untreated sleep apnea and Parkinson’s disease. Veterans with OSA showed 1.61 additional cases of Parkinson’s per 1,000 people at six years from OSA diagnosis compared to those without the condition. Compared to those without the condition, veterans with OSA were nearly twice as likely to develop Parkinson’s. The link between OSA and Parkinson’s was even more pronounced in female veterans.

OSA can be effectively treated using CPAP machines. Importantly, the study found that early CPAP treatment reduced the risk of developing Parkinson’s. Veterans who began CPAP use within two years of their diagnoses were about 30% less likely to develop Parkinson’s compared to those who didn’t use CPAP.

In addition, for those who did eventually get diagnosed with Parkinson’s, the study showed that using CPAP early after an OSA diagnosis was associated with a reduction in the rates of falls, fractures and mortality.

Man sitting in bed cannot sleep

Highlights

  • The study analyzed health records of more than 11 million U.S. veterans over a 23-year period.
  • People with untreated obstructed sleep apnea had nearly twice the risk of developing Parkinson's disease compared to those without OSA.
  • The link between OSA and Parkinson's risk was even stronger in female veterans.
  • Early CPAP treatment in those with OSA significantly reduced the number of Parkinson's cases.
  • For those who developed Parkinson’s, early CPAP use was linked to reduced risk of falls, fractures, and mortality.

What Does This Mean?

This research suggests that obstructive sleep apnea may be a modifiable risk factor for Parkinson’s disease — meaning it can potentially be treated. It is important to note that the results of this study are correlations; the study did not prove that sleep apnea causes Parkinson’s, or that CPAP can prevent the development of Parkinson’s. However, the links between OSA, CPAP use, and Parkinson’s highlight the importance of diagnosing and managing sleep disorders early.

Additionally, these results support similar findings from the dementia field, in which a study found that CPAP treatment of OSA was associated with reduced odds of developing dementia.

OSA is extremely common and underdiagnosed. The Global Burden of Obstructive Sleep Apnea study found OSA to be a widespread concern “estimated to affect nearly 936 million adults aged between 30 and 69 worldwide.” Because of how widespread OSA is, linking it to Parkinson’s means there is a large opportunity to reduce risk and improve outcomes through better detection and treatment.

What Do These Findings Mean for People with Parkinson’s Right Now?

While this research does not change day-to-day treatment for people already living with Parkinson’s, it reinforces the importance of addressing sleep problems, which are already common in Parkinson’s.

Poor sleep can worsen movement and non-movement symptoms, affect quality of life and impact overall health. Research continues to link sleep apnea with negative health outcomes. If you experience symptoms of sleep apnea, such as loud snoring, gasping during sleep or excessive daytime fatigue, talk to your doctor. A sleep study can determine if you have OSA, and treatments like CPAP can help improve your sleep quality and potentially support your overall health.

Learn More

The Parkinson’s Foundation believes in empowering the Parkinson’s community through education. Learn more about PD and sleep through our resources below, or by calling our free Helpline at 1-800-4PD-INFO (1-800-473-4636) for answers to your Parkinson’s questions.

Back to Top